Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methylation-controlled J protein (MCJ) for treatment of liver disease and altering mitochondrial metabolism

Methylation-controlled J protein (MCJ) for treatment of liver disease and altering mitochondrial metabolism

US Patent 10583169 · Granted Mar 10, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Administering methylation-controlled J protein (MCJ) SIRNA to a kidney cell2023
Administering methylation-controlled J protein (MCJ) SIRNA to a kidney cell2023
Treatment with methylation-controlled J protein (MCJ)2020
Treatment with methylation-controlled J protein (MCJ)2020
Methods and compositions to treat drug-induced diseases and conditions2020
MCJ agonists and uses therefor2019
Methods and products relating to GSK3β regulation2018
Methods and products relating to GSK3β regulation2013
Anti-methylation-controlled j protein antibodies and uses thereof2013